MBOT — Microbot Medical Share Price
0.000.00%
Last trade - 00:00- $16.76m
- $10.41m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.69 | ||
| Price to Tang. Book | 2.69 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -168.68% | ||
| Return on Equity | -186.26% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Microbot Medical Inc. is a pre-clinical medical device company. The Company is specializing in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is primarily focused on leveraging its robotic technologies with surgical robotics to improve surgical outcomes for patients. Its technological platforms include LIBERTY and NovaCross. Using its LIBERTY Endovascular Robotic Surgical System, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. LIBERTY Endovascular Robotic Surgical System addresses the needs of interventional cardiology, interventional radiology and interventional neuroradiology markets.
Directors
- Harel Gadot CHM (48)
- David Ben Naim CFO (51)
- Simon Sharon CTO (62)
- Eyal Morag OTH (56)
- Yoseph Bornstein IND (63)
- Scott Burell IND (56)
- Prattipati Laxminarain IND (64)
- Martin Madden IND (61)
- Aileen Stockburger IND (59)
- Tal Wenderow IND (47)
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- August 2nd, 1988
- Public Since
- March 25th, 1992
- No. of Shareholders
- 97
- No. of Employees
- 22
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 15,965,633
- Address
- 25 RECREATION PARK DR SUITE 108, HINGHAM, 02043
- Web
- http://www.microbotmedical.com/
- Phone
- +1 9089385561
- Contact
- Michael Polyviou
- Auditors
- Brightman Almagor Zohar & Co
Upcoming Events for MBOT
Microbot Medical Inc Annual Shareholders Meeting
Q3 2024 Microbot Medical Inc Earnings Release
Similar to MBOT
180 Life Sciences
NASDAQ Capital Market
Abeona Therapeutics
NASDAQ Capital Market
ABVC Biopharma
NASDAQ Capital Market
Acesis Holdings
NASDAQ Capital Market
Achieve Life Sciences
NASDAQ Capital Market
FAQ
What is the Microbot Medical share price?
As of Today at 22:03 UTC, shares in Microbot Medical are trading at $1.04. This share price information is delayed by 15 minutes.
How has the Microbot Medical share price performed this year?
Shares in Microbot Medical last closed at $1.04 and the price had moved by -67.4% over the past 365 days. In terms of relative price strength the Microbot Medical share price has underperformed the S&P500 Index by -74.06% over the past year.
What are the analyst and broker recommendations for Microbot Medical?
The overall consensus recommendation for Microbot Medical is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Microbot Medical dividend yield?
Microbot Medical does not currently pay a dividend.
Does Microbot Medical pay a dividend?
Microbot Medical does not currently pay a dividend.
When does Microbot Medical next pay dividends?
Microbot Medical does not currently pay a dividend.
How do I buy Microbot Medical shares?
To buy shares in Microbot Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Microbot Medical?
As of the previous close price of $1.04, shares in Microbot Medical had a market capitalisation of $16.60m.
Where are Microbot Medical shares listed?
Here are the trading details for Microbot Medical:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: MBOT
What kind of share is Microbot Medical?
Based on an overall assessment of its quality, value and momentum Microbot Medical is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Microbot Medical share price forecast for 2024?
The analyst consensus target price for shares in Microbot Medical is $7.00. That is 573.08% above the last closing price of $1.04.
Analysts covering Microbot Medical currently have a consensus Earnings Per Share (EPS) forecast of -$0.66 for the next financial year.
What is the trend in the Microbot Medical share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Microbot Medical. Over the past six months, its share price has underperformed the S&P500 Index by -33.18%.
As of the last closing price of $1.04, shares in Microbot Medical were trading -17.54% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Microbot Medical PE Ratio?
The Microbot Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.04.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Microbot Medical?
Microbot Medical's management team is headed by:
- Harel Gadot - CHM
- David Ben Naim - CFO
- Simon Sharon - CTO
- Eyal Morag - OTH
- Yoseph Bornstein - IND
- Scott Burell - IND
- Prattipati Laxminarain - IND
- Martin Madden - IND
- Aileen Stockburger - IND
- Tal Wenderow - IND